Partho P. Sengupta is the Director of Cardiac Ultrasound Research and Core Lab and an Associate Professor of Medicine in Cardiology at Mount Sinai’s Zena and Michael A. Wiener Cardiovascular Institute and the Marie-Josée and Henry R. Kravis Center for Cardiovascular Health.
Dr Sengupta graduated as a cardiology fellow from All India Institute of Medical Sciences in New Delhi and then completed his clinical residency and cardiology fellowship from Mayo Clinic Rochester and Arizona respectively. He has over 100 peer-reviewed publications that have focused on the analysis of structure, function, and flow patterns in the cardiovascular system. The primary goal of his research is to detect early stages of cardiovascular disease using state-of-the-art cardiac ultrasound technologies.
Prior to his move to Mount Sinai New York, he served as the Director of Noninvasive Cardiology and Cardiac Imaging at University of California, Irvine. He is an Associate Editor for the Journal of American College of cardiology: Imaging and currently serves as a Board of Director for the American Society of Echocardiography and as the Chair of the 2013 ASE World Summit on Echocardiography.
He has won several excellence awards including ASE's Young Investigator Award in 2004, Mayo Clinic Research Award in 2007, Mayo Brother's Distinguished Fellowship Award in 2009 and AACIO Young Investigator Award in 2010. He was awarded ASE's 14th Feigenbaum Lecturership for recognizing his significant contributions to research in the field of echocardiography and his potential to continue at a high level of achievement. He delivered ASE’s first-ever presentation using hologram technology at The American Society of Echocardiography's 2013 24th Annual Scientific Sessions on July 1 inMinneapolis, Minnesota. His futuristic ideas, investigative skills and international work have been widely acclaimed by major media outlets including heart.org and Forbes.
Multi-Disciplinary Training Area
Biophysics and Systems Pharmacology [BSP]
EnglishDownload the CV
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Below are financial relationships with industry reported by Dr. Sengupta during 2016 and/or 2017. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
- Edwards Lifesciences
- Saffron Technology
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.